We are 144,765 members in 73 forums discussing 114,531 topics.

Help with Abbreviations

All TopicsForum: Clinical Trials, Research, News, and Study Results → Topic: TAILORx Trial Preliminary Results?

Topic: TAILORx Trial Preliminary Results?

Forum: Clinical Trials, Research, News, and Study Results — Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

Posted on: Mar 23, 2011 06:23PM

chamonix wrote:

Are there any preliminary results available on the TAILORx trial yet? When do you expect that data to be known?

Log in to post a reply

Posts 1 - 2 (2 total)

Log in to post a reply

Mar 2, 2012 07:30PM Chris13 wrote:

bump

"To attend to the moment is to attend to eternity." 2 ILC tumors 1.6. 1/4 positive nodes. Oncotypes 8 & 15. No rads/chemo.

Dx 2/24/2012, ILC, 1cm, Stage IIa, Grade 1, 1/4 nodes, ER+/PR+, HER2-Dx 2/24/2012, ILC, 1cm, Stage II, Grade 1, 1/4 nodes, ER+/PR+, HER2-Surgery 05/01/2012 Reconstruction: DIEP flap (Right)Surgery 05/01/2012 Mastectomy (Right); Lymph Node Removal: Sentinel Lymph Node Dissection (Right)Hormonal Therapy 08/01/2012 Arimidex
Log in to post a reply

Mar 3, 2012 08:15AM otter wrote:

The TAILORx trial completed its "accrual" phase in 2010. The target accrual was huge:  they needed 10,000 eligible volunteers:  http://www.prweb.com/releases/2010/10/prweb4686754.htm

According to the Genomic Health website (that's the company that does the Oncotype DX testing), results are not expected until 2015:  http://www.genomichealth.com/Publications/ClinicalTrials.aspx  That makes sense, because the study is looking at recurrence rates in women who do, or do not, get chemo.  Two of the main endpoints of the trial are "disease-free survival" and "overall survival."  It takes a long time (many years) to gather those numbers, especially among women with ER+ tumors.  I've read that the women participating in the study will be followed for 20 years.

Here's a link to the ECOG (Eastern Cooperative Oncology Group) page with more information about the TAILORx trial. ECOG is coordinating the study, so they should be posting new information on their website as it becomes available:  http://www.ecog.org/general/tailorx.html

Finally, for readers who aren't familiar with the TAILORx clinical trial, here's a short explanation in Q&A format from the National Cancer Institute:  http://www.cancer.gov/newscenter/qa/2006/TAILORxQandA

otter (who, with a score of 26, would have received chemo anyway if enrolled in the study)

Dx IDC, Stage I, Grade 2, 0/3 nodes, ER+/PR-, HER2-